Sign In
Free Newsletter
Citius Pharmaceuticals’ spinoff plans advance
The Cranford-based company enlisted Maxim Group LLC to serve as financial advisor to its wholly owned subsidiary, Citius Acquisition Corp. Inc., in connection with the move.
Cooper Health offers ‘cutting edge’ treatment for heart failure
“Barostim has the capability to help reduce heart failure symptoms and improve quality of life," said Dr. Ketan Gala, clinical cardiologist and medical director of the Advanced Heart Failure Program at Cooper.
FDA clears Merck’s Keytruda for expanded use
The move is the first full approval for an immunotherapy based on a predictive biomarker. In 2022, the best-selling cancer treatment's sales grew 22% to $20.9 billion.
Industry veteran named CEO of Healthcare Businesswomen’s Association
"With her extensive background championing innovation and equity in the workplace ... Mary [Stutts] truly embodies HBA's mission as well as our 2023 theme Powering the Possibilities," Board Chair Julie Ross said.
South Jersey doctor pleads guilty to health care fraud conspiracy
The more than $5 million scheme targeted state and local health benefits programs and other insurers, including submitting fraudulent claims for medically unnecessary prescriptions.
Two hospitals, three NJ counties receive $16.3M to cover COVID costs
The funding, announced by U.S. Sens. Robert Menendez and Cory Booker, comes via the Federal Emergency Management Agency.
Johnson & Johnson will seek US Supreme Court review of talc bankruptcy case
In a March 22 ruling, the Third Circuit Court in Philadelphia upheld an earlier decision to dismiss because neither J&J nor its subsidiary was in “financial distress.”
After its spinoff from BD, embecta forges new identity
Today, the company is the leading producer of diabetes injection devices, manufacturing approximately 8 billion instruments annually for an estimated 30 million patients.
PTC Therapeutics CEO Peltz retires from company he founded
Announcing the change in leadership, the company noted that under Dr. Stuart Peltz it has grown from a research organization with expertise in the control of RNA processes to a publicly traded, integrated, global biopharmaceutical company.
Princeton Cancer Center receives $2.5M for geriatric cancer research
The funding from the Bristol Myers Squibb Foundation will support a new program that aims to provide a better understand of geriatric cancer and increase outreach to seniors in central New Jersey.
JFK University Medical Center launches GERD program
Dr. Annie Laurie Benzie will lead the service, aimed at helping patients suffering from gastroesophageal reflux disease and related illnesses.
BeiGene reaches milestone at $700M Hopewell facility
Eleven months after breaking ground, the biopharmaceutical company laid the last piece of structural steel for its new manufacturing and R&D site at the Princeton West Innovation Campus.
